TGA Consultation — Medicines Labelling & Packaging

The Australian Dental Industry Association (ADIA) is reviewing a consultation paper issued by the Therapeutic Goods Administration (TGA) concerning recommended changes to the presentation of information on the labels and packages of medicines.

The proposals improve the visual presentation of the labels and packages of medicines are aimed to enable the safe use of medicines by consumers and cover: products purchased from a supermarket or a pharmacy without a prescription, or products purchased following a consultation with a health professional, usually with a prescription. The TGA’s intent is to regulatory solutions to address widely recognised consumer safety risks associated with the current regulations for the labelling and packaging of medicines.

        TGA Discussion Paper:  Medicine labelling and packaging [PDF]

ADIA has been invited by the TGA to tender whether or not the dental industry supports the proposed changes. Further advice has also been requested on the impacts of likely changes, that is, what is the likely cost to the dental industry.

TheADIA-DRC Dental Regulation Committee will prepare a response on behalf of ADIA members and the broader dental industry and if you have any comments concerning the proposals as outlined in the above referenced paper, please contact the ADIA national office.

To keep up to date on this issue follow ADIA on Twitter @AusDental or contact the ADIA national office via email at dental.regulation@adia.org.au or by telephone on 1300 943 094 (internationally on +61 2 9319 5631).